Notice Number: NOT-DA-18-005
Key Dates
Release Date: February 15, 2018
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The purpose of this Notice is to inform potential applicants that the National Institute on Drug Abuse (NIDA) will participate, effective immediately, in PA-18-653, "Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R34 Clinical Trial Optional)" .
The following sections of PA-18-653 (shown in italics) have been updated to reflect the participation of the NIDA in this Funding Opportunity Announcement (FOA).
Part 1. Overview Information
Components of Participating Organizations
National Institute of Mental Health (NIMH)
National Institute on Drug Abuse (NIDA)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.242, 93.279
Section VII. Agency Contacts
Scientific/Research Contact(s)
Richard A. Jenkins, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-1923
Email: jenkinsri@mail.nih.gov
Financial/Grants Management Contact(s)
Edith Davis
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6697
Email: edavis1@nida.nih.gov
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Richard A. Jenkins, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-1923
Email: jenkinsri@mail.nih.gov